Subsite-specific differences of estrogen receptor beta expression in the normal colonic epithelium: Implications for carcinogenesis and colorectal cancer epidemiology

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 5, 2010, Pages 614-619

  Papaxoinis, Kostis ^a   Triantafyllou, Kostas ^b   Sasco, Annie J ^c   Nicolopoulou Stamati, Polyxeni ^a   Ladas, Spiros D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Attikon University General Hospital   (Greece)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Colon; Colorectal cancer; Endocrine disrupters; Estrogen receptor beta; Xenoestrogens

Indexed keywords

ESTROGEN RECEPTOR BETA; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; UVOMORULIN;

ADULT; AGED; ANEMIA; APOPTOSIS; ARTICLE; CANCER EPIDEMIOLOGY; CELL ADHESION; CELL PROLIFERATION; COLON BIOPSY; COLON CARCINOGENESIS; COLON MUCOSA; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; APOPTOSIS; BIOPSY; CELL ADHESION; CELL DIVISION; COLON, ASCENDING; COLON, DESCENDING; COLONOSCOPY; COLORECTAL NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 77951276173     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328335ef50     Document Type: Article

References (42)

1. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88:2398-2424.
2. Matanoski G, Tao X, Almon L, Adade AA, Davies-Cole JO. Demographics and tumor characteristics of colorectal cancers in the United States, 1998-2001. Cancer 2006; 107:1112-1120.
3. Saltzstein SL, Behling CA, Savides TJ. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1998; 82:1408-1410.
4. Cress RD, Morris C, Elisson GL, Goodman MT. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ ethnicity, 1992-2001. Cancer 2006; 107:1142-1152.
5. Fric P, Sovova V, Sloncova E, Lojda Z, Jirásek A, Cermák J. Different expression of some molecular markers in sporadic cancer of the left and right colon. Eur J Cancer Prev 2000; 9:265-268.
6. Glebov OK, Rodriguez LM, Nakahara K, Jenkins J, Cliatt J, Humbyrd CJ, et al. Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol Biomarkers Prev 2003; 12:755-762.
7. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005; 54:374-384.
8. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord 2001; 1:1-12.
9. Slattery ML, Potter JD, Curtin K, Fitzpatrick F, Herrick J, Potter JD, et al. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 2001; 61:126-130.
10. Gustafsson JA. Estrogen receptor b-a new dimension in estrogen mechanism of action. J Endocrinol 1999; 163:379-383.
11. Wong NA, Malcomson RD, Jodrell DI, Groome NP, Harrison DJ, Saunders PT. ER beta isoforms expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005; 207:53-60.
12. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW. Selective loss of estrogen receptor b in malignant human colon. Cancer Res 2000; 60:245-248.
13. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, et al. Oestrogen receptor beta (ERb) is abundantly expressed in normal colonic mucosa but declines in colon adenocarcinoma paralleling the tumor's dedifferentiation. EurJ Cancer 2003; 39:1251-1258.
14. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genetics 1994; 7:536-540.
15. Shanmugathasan M, Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 2000; 50:273-279.
16. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006; 12:413-424.
17. Polyak K, Hamilton SR, Vogelstein B, Kinzler KW. Early alterations of cell-cycle-regulated gene expression in colorectal neoplasia. Am J Pathology 1996; 149:381-387.
18. Merritt AJ, Potten CS,Watson AJM, Loh DY, Nakayama K, Nakayama K, et al. Differential expression of Bcl-2 in intestinal epithelium. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Science 1995; 108:2261-2271.
19. Berkhout M, Gosens M, Brouwer KM, Peters WH, Nagengast FM, van Krieken JH, et al. Loss of extracellular E-cadherin in the normal mucosa of duodenum and colon of patients with familial adenomatous polyposis. Hum Pathol 2006; 37:1389-1399.
20. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, et al. Role of estrogen receptor beta in colonic epithelium. Proc Natl Acad Sci U S A 2006; 103:2959-2964.
21. Witte D, Chirala M, Younes A, Hultenby K, Schwend T, Omoto Y, et al. Estrogen receptor b is expressed in human colorectal adenocarcinoma. Hum Pathol 2001; 32:940-944.
22. Diaz LK, Sneige N. Estrogen receptor analysis for breast cancer. Current issues and keys to increasing testing accuracy. Adv Anat Pathol 2005; 12:10-19.
23. Kristt D, Winston GJ, Mellov MM, Veltman V, Koren R. Patterns of proliferative changes in crypts bordering colonic tumors: zonal histology and cell cycle marker expression. Pathol Oncol Res 1999; 5:279-303.
24. Terpstra OT, Van Blankenstein M, Dees J, Eilers GA. Abnormal pattern of cell proliferation in the entire colonic mucosa of patients with colon adenoma or cancer. Gastroenterology 1987; 92:704-708.
25. Ponz de Leon M, Roncucci L, Di Donato P, Tassi L, Smerieri O, Amorico MG, et al. Pattern of epithelial cell proliferation in colorectal mucosa of normal subjects and of patients with adenomatous polyps or cancer of the large bowel. Cancer Res 1988; 48:4121-4126.
26. Paspatis GA, Zizi A, Chlouverakis GJ, Giannikaki ES, Vasilakaki T, Elemenoglou I, et al. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies. Am J Gastroenterol 1998; 93:1472-1477.
27. Vobecky J, Leduc C, Devroede G. Sex differences in the changing anatomic distribution of colorectal carcinoma. Cancer 1984; 54:3065-3069.
28. Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer 1997; 80:193-197.
29. Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum 2002; 45:1035-1040.
30. Saltzstein SL, Behling CA. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: a study of 213 383 cases from the California Cancer Registry. J Clin Gastroenterol 2007; 41:173-177.
31. Greene FL. Distribution of colorectal neoplasms. A left to right shift of polyps and cancer. Am Surg 1983; 49:62-65.
32. Papatheodoridis GV, Triantafyllou K, Tzouvala M, Paspatis G, Xourgias V, Karamanolis DG. Characteristics of rectosigmoid adenomas as predictors of synchronous advanced proximal colon neoplasms. Am J Gastroenterol 1996; 91:1809-1813.
33. Kim MS, Park YJ. Detection and treatment of synchronous lesions in colorectal cancer: the clinical implication of perioperative colonoscopy. World J Gastroenterol 2007; 13:4108-4111.
34. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004; 14:473-486.
35. Gee D. Late lessons from early warnings: toward realism and precaution with endocrine-disrupting substances. Environ Health Perspect 2006; 114:152-160.
36. Waring RH, Harris RM. Endocrine disrupters: a human risk? Mol Cell Endocrinol 2005; 244:2-9.
37. Mueller SO. Xenoestrogens: mechanisms of action and detection methods. Anal Bioanal Chem 2004; 378:582-587.
38. Witorsch RJ. Endocrine disruptors: can biological effects and environmental risks be predicted? Regul Toxicol Pharmacol 2002; 36:118-130.
39. Brody JG, Rudel RA. Environmental pollutants and breast cancer. Environ Health Perspect 2003; 111:1007-1019.
40. Robert SA, Strombom I, Trentham-Dietz A, Hampton JM, McElroy JA, Newcomb PA, et al. Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects. Epidemiology 2004; 15:442-450.
41. Wu X, Cokkinides V, Chen VW, Nadel M, Ren Y, Martin J, et al. Associations of subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis with county-level poverty, by race and sex. Cancer 2006; 107:1121-1127.
42. Cappelletti V, Saturno G, Miodini P, Kö rner W, Daidone MG. Selective modulation of ER-beta by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol Life Sci 2003; 60:567-576.